Uenver, Y. B. Et Al. 2009. Relationships between clinical measures of visual function and anatomic changes associated with bevacizumab treatment for choroidal neovascularization in age-related macular degeneration. EYE , vol.23, no.2 , 453-460.

Uenver, Y. B., Yavuz, G. A., Bekiroglu, N., Presti, P., Li, W., & Sinclair, S. H., (2009). Relationships between clinical measures of visual function and anatomic changes associated with bevacizumab treatment for choroidal neovascularization in age-related macular degeneration. EYE , vol.23, no.2, 453-460.

Uenver, Y. Et Al. "Relationships between clinical measures of visual function and anatomic changes associated with bevacizumab treatment for choroidal neovascularization in age-related macular degeneration," EYE , vol.23, no.2, 453-460, 2009

Uenver, Y. B. Et Al. "Relationships between clinical measures of visual function and anatomic changes associated with bevacizumab treatment for choroidal neovascularization in age-related macular degeneration." EYE , vol.23, no.2, pp.453-460, 2009

Uenver, Y. B. Et Al. (2009) . "Relationships between clinical measures of visual function and anatomic changes associated with bevacizumab treatment for choroidal neovascularization in age-related macular degeneration." EYE , vol.23, no.2, pp.453-460.

@article{article, author={Y. B. Uenver Et Al. }, title={Relationships between clinical measures of visual function and anatomic changes associated with bevacizumab treatment for choroidal neovascularization in age-related macular degeneration}, journal={EYE}, year=2009, pages={453-460} }